These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21196624)

  • 1. Drug interaction between rifampicin and sirolimus in transplant patients.
    Ngo BT; Pascoe M; Khan D
    Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):112-5. PubMed ID: 21196624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine-rifampicin interaction in a patient with pulmonary tuberculosis.
    Peritogiannis V; Pappas D; Antoniou K; Hyphantis T; Mavreas V
    Gen Hosp Psychiatry; 2007; 29(3):281-2. PubMed ID: 17484952
    [No Abstract]   [Full Text] [Related]  

  • 3. Rifampicin-induced renal toxicity during retreatment of patients with pulmonary tuberculosis.
    Rekha VV; Santha T; Jawahar MS
    J Assoc Physicians India; 2005 Sep; 53():811-3. PubMed ID: 16334628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
    Sayin B; Karakayali H; Colak T; Sevmis S; Pehlivan S; Demirhan B; Haberal M
    Transplant Proc; 2009 Sep; 41(7):2789-93. PubMed ID: 19765436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial.
    Pascual J; del Castillo D; Cabello M; Pallardó L; Grinyó JM; Fernández AM; Brunet M
    Transplantation; 2010 Apr; 89(8):994-1000. PubMed ID: 20335831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
    Sundberg AK; Rohr MS; Hartmann EL; Adams PL; Stratta RJ
    Clin Transplant; 2004; 18 Suppl 12():61-6. PubMed ID: 15217410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of pulmonary tuberculosis with acute renal failure caused by readministration of rifampicin].
    Kuroda F; Yagi T; Yamagishi F; Mizutani F; Sasaki Y; Wada A
    Kekkaku; 1999 Nov; 74(11):803-7. PubMed ID: 10599213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: incidence, risk factors, progression, and prognosis.
    Chueh SC; Kahan BD
    Transplantation; 2003 Jul; 76(2):375-82. PubMed ID: 12883196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug interaction between cyclosporine and two antimicrobial agents, josamycin and rifampicin, in organ-transplanted patients.
    Capone D; Aiello C; Santoro GA; Gentile A; Stanziale P; D'Alessandro R; Imperatore P; Basile V
    Int J Clin Pharmacol Res; 1996; 16(2-3):73-6. PubMed ID: 9063759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Specific features of acute renal failure in patients treated with rifampicin].
    Munteanu L; Golea O; Nicolicioiu M; Tudorache V
    Pneumologia; 2002; 51(1):15-20. PubMed ID: 12043271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive drug monitoring of sirolimus and cyclosporine in pediatric patients.
    Oellerich M; Armstrong VW; Streit F; Weber L; Tönshoff B
    Clin Biochem; 2004 Jun; 37(6):424-8. PubMed ID: 15183289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of sirolimus (rapamycin) in subjects with mild to moderate hepatic impairment.
    Zimmerman JJ; Lasseter KC; Lim HK; Harper D; Dilzer SC; Parker V; Matschke K
    J Clin Pharmacol; 2005 Dec; 45(12):1368-72. PubMed ID: 16291711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Worsening of steroid dependent asthma : A possible role of rifampicin.
    Gupta D; Yadav S; Behera D; Jindal SK
    Indian J Chest Dis Allied Sci; 1995; 37(1):35-8. PubMed ID: 16892737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus as an alternative to anticalcineurin therapy in heart transplantation: experience of a single center.
    Fernandez-Valls M; Gonzalez-Vilchez F; de Prada JA; Ruano J; Ruisanchez C; Martin-Duran R
    Transplant Proc; 2005 Nov; 37(9):4021-3. PubMed ID: 16386615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteinuria after conversion to sirolimus in renal transplant recipients.
    Sahin GM; Sahin S; Kantarci G; Ergin H
    Transplant Proc; 2006 Dec; 38(10):3473-5. PubMed ID: 17175308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rifampicin induced thrombocytopenia.
    Garg R; Gupta V; Mehra S; Singh R; Prasad R
    Indian J Tuberc; 2007 Apr; 54(2):94-6. PubMed ID: 17575681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rifampicin-associated acute renal failure and hemolysis: a rather uncommon but severe complication.
    Manika K; Tasiopoulou K; Vlogiaris L; Lada M; Papaemmanouil S; Zarogoulidis K; Kioumis I
    Ren Fail; 2013 Sep; 35(8):1179-81. PubMed ID: 23883374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of renal function after islet transplant alone or islet-after-kidney transplantation using a sirolimus/tacrolimus-based immunosuppressive regimen.
    Andres A; Toso C; Morel P; Demuylder-Mischler S; Bosco D; Baertschiger R; Pernin N; Bucher P; Majno PE; Bühler LH; Berney T
    Transpl Int; 2005 Nov; 18(11):1226-30. PubMed ID: 16221151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azoospermia in a renal transplant recipient during sirolimus (rapamycin) treatment.
    Skrzypek J; Krause W
    Andrologia; 2007 Oct; 39(5):198-9. PubMed ID: 17714220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.